In Brief Katie Coleman named senior advisor for translational innovation at OSUCC–James January 16, 2026Vol.52 No.02
In Brief Alex Bates named director for executive communications at the OSUCCC–James January 16, 2026Vol.52 No.02
Clinical Roundup Tecvayli monotherapy demonstrates superior PFS and OS vs. standard of care in MM January 16, 2026Vol.52 No.02
Clinical Roundup Rybrevant leads to anti-tumor activity and durable responses in CRC, phase I/II follow-up results show January 16, 2026Vol.52 No.02
Clinical Roundup Bepirovirsen demonstrates positive results in chronic hepatitis B, phase III trials show January 16, 2026Vol.52 No.02
Clinical Roundup Mutation predicts chemoresistance and better responses to immunotherapy in advanced bladder cancer, MD Anderson study finds January 16, 2026Vol.52 No.02
Clinical Roundup Mayo develops AI tool that predicts prostate cancer recurrence January 16, 2026Vol.52 No.02
Clinical Roundup LSU researchers identify proteins linked to prostate cancer January 16, 2026Vol.52 No.02
Drugs & Targets FDA accepts NDA for pimicotinib for treatment of tenosynovial giant cell tumor January 16, 2026Vol.52 No.02
Drugs & Targets City of Hope, Cellares collaborate to automate manufacturing of solid tumor CAR T-cell therapy January 16, 2026Vol.52 No.02
